Docstoc

Scholl Athlete's Foot Powder

Document Sample
Scholl Athlete's Foot Powder Powered By Docstoc
					28/09/2006

Scholl Athlete's Foot Powder

Table of Contents

      1. NAME OF THE MEDICINAL PRODUCT
      2. QUALITATIVE AND QUANTITATIVE COMPOSITION
      3. PHARMACEUTICAL FORM
      4. CLINICAL PARTICULARS
      4.1 Therapeutic indications
      4.2 Posology and method of administration
      4.3 Contraindications
      4.4 Special warnings and precautions for use
      4.5 Interaction with other medicinal products and other forms of
       interaction
      4.6 Pregnancy and lactation
      4.7 Effects on ability to drive and use machines
      4.8 Undesirable effects
      4.9 Overdose
      5. PHARMACOLOGICAL PROPERTIES
      5.1 Pharmacodynamic properties
      5.2 Pharmacokinetic properties
      5.3 Preclinical safety data
      6. PHARMACEUTICAL PARTICULARS
      6.1 List of excipients
      6.2 Incompatibilities
      6.3 Shelf life
      6.4 Special precautions for storage
      6.5 Nature and contents of container
      6.6 Special precautions for disposal and other handling
      7. MARKETING AUTHORISATION HOLDER
      8. MARKETING AUTHORISATION NUMBER(S)
      9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE
       AUTHORISATION
      10. DATE OF REVISION OF THE TEXT




1. NAME OF THE MEDICINAL PRODUCT
 Scholl Athlete's Foot Powder.
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
 Tolnaftate BP 1.0% w/w.

3. PHARMACEUTICAL FORM
 Powder for topical application.

4. CLINICAL PARTICULARS


4.1 Therapeutic indications
 Prevention and treatment of Athlete's Foot.

4.2 Posology and method of administration
  Wash and dry infected area and apply twice daily, or as directed by a
  doctor. Dust feet liberally, especially between toes. For added protection
  dust on socks, hosiery and inside shoes. Continue treatment for two weeks
  after symptoms disappear.

4.3 Contraindications
 Not recommended for nail or scalp infections.

4.4 Special warnings and precautions for use
  Keep out of the reach of children. For external use only. Keep out of the
  eyes. If symptoms do not improve within 10 days, discontinue use and
  consult your doctor.

4.5 Interaction with other medicinal products and other forms of
interaction
  Not relevant to topical use.

4.6 Pregnancy and lactation
 No known restrictions.

4.7 Effects on ability to drive and use machines
 None stated.

4.8 Undesirable effects
 None stated.

4.9 Overdose
 Not relevant to topical use.
5. PHARMACOLOGICAL PROPERTIES


5.1 Pharmacodynamic properties
  Tolnaftate: topical antifungal agent (ATC Classification D01AE).

5.2 Pharmacokinetic properties
  Not applicable for a topical dosage form of this type.

5.3 Preclinical safety data
 None stated.

6. PHARMACEUTICAL PARTICULARS


6.1 List of excipients
 Talc; Starch.

6.2 Incompatibilities
 None stated.

6.3 Shelf life
 5 years.

6.4 Special precautions for storage
 Store below 25oC.

6.5 Nature and contents of container
  High density poly-ethylene powder bottle with sifter assembly. Pack size:
  75g

6.6 Special precautions for disposal and other handling
 No special precautions required.

7. MARKETING AUTHORISATION HOLDER
  Scholl Consumer Products Ltd. Venus, 1 Old Park Lane, Trafford Park,
  Manchester M41 7HA

8. MARKETING AUTHORISATION NUMBER(S)
 PL 0587/0007
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
 24th April 1985 / 13th January
 2005

10. DATE OF REVISION OF THE TEXT
 May 2006

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:7
posted:12/11/2011
language:English
pages:4